<DOC>
	<DOCNO>NCT00440492</DOCNO>
	<brief_summary>The purpose study determine PLA-695 change blood concentration methotrexate administer together .</brief_summary>
	<brief_title>Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Men woman nonchildbearing potential rheumatoid arthritis ( RA ) , age 18 75 year RA disease onset 16 year age disease least 6 month Must receive stable , welltolerated oral dose methotrexate ( 5 25 mg ) take weekly least 3 month Evidence unstable clinically significant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>